Apollo Endosurgery Inc IPO-Jahr
Was ist das IPO-Jahr von Apollo Endosurgery Inc?
IPO-Jahr von Apollo Endosurgery Inc ist 2012
Was ist die Definition von IPO-Jahr?
Börsengang ist ein öffentliches Angebot, bei dem Aktien eines Unternehmens normalerweise an institutionelle Anleger verkauft werden, die ihrerseits erstmals an einer Wertpapierbörse an die breite Öffentlichkeit verkauft werden.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
IPO-Jahr von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Apollo Endosurgery Inc
Was macht Apollo Endosurgery Inc?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Unternehmen mit ipo-jahr ähnlich Apollo Endosurgery Inc
- American Century ETF Trust hat IPO-Jahr von 2011
- Sino Harbour hat IPO-Jahr von 2011
- Horizons Gold Prod Equty Cvrd C hat IPO-Jahr von 2011
- HFX hat IPO-Jahr von 2011
- Dark Horse Resources hat IPO-Jahr von 2011
- Om Metals Infraprojects hat IPO-Jahr von 2011
- Apollo Endosurgery Inc hat IPO-Jahr von 2012
- Evertec Inc hat IPO-Jahr von 2013
- Virtus Health hat IPO-Jahr von 2013
- Antero Resources Corp hat IPO-Jahr von 2013
- Murphy USA Inc hat IPO-Jahr von 2013
- Kodal Minerals Plc hat IPO-Jahr von 2013
- Agios Pharmaceuticals Inc hat IPO-Jahr von 2013